Facebook
  1. Home
  2. Solutions
  3. ICON’s Elite Sites Program

ICON’s Elite Sites Program

Delivering fast, reliable, and impactful research outcomes

The Elite Sites, ICON’s VIP program for top-tier site networks, was designed to offer an upper echelon for those networks who have set themselves apart. These networks have been meticulously selected for their high-performance, demonstrated faster start-up, and ability to meet or exceed recruitment commitments. With the use of ICON’s Elite Site program, the aim is for clients to increase reliability with delivery, reduce site or country footprint, shorten overall study timelines and get drugs to market faster.

Expertise

ICON Elite Sites have been chosen to align with select therapeutic areas in which these sites have shown the ability to be true differentiators for our clients and study teams. However, most sites are multi-therapeutic and can support a wide array of trials.

Engaging ICON’s Elite Sites increases certainty for dependable and competitive enrolment, access to experience in key therapeutic areas, and unmatched support from key opinion leaders across the world. 

Expedited start-up

ICON’s Elite Sites are supported by streamlined processes and dedicated resources, with governance & accountability. Fully executed Master Clinical Trial Agreements (MCTAs) are in place with each of our Elite Site networks to help surpass startup timelines and to ensure patients are enrolled into studies at a faster rate. Networks within the Elite Sites Program have centralised services to help streamline study start-up, including, but not limited to, site feasibility, budgeting, contracting and recruitment. 

ICON is dedicated to fostering collaboration among top-tier research site networks to accelerate the development of groundbreaking therapies and treatments. With a steadfast commitment to quality, integrity, and patient-centric care, ICON developed the Elite Sites Program to serve as a pivotal hub for conducting cutting-edge clinical trials across various therapeutic areas. By bringing together a diverse range of specialised capabilities and fostering close partnerships between our sites and clients, we strive to deliver timely, reliable, and impactful clinical research outcomes.

In this section

Connect with us